N-acetylserotonin activates TrkB receptor in a circadian rhythm

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 8, 2010, Pages 3876-3881

  Jang, Sung Wuk ^a   Liu, Xia ^a   Pradoldej, Sompol ^a   Tosini, Gianluca ^b   Chang, Qiang ^c   Iuvone, P Michael ^a   Ye, Keqiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Depression; Neuroprotection; Neurotrophin; Serotonin

Indexed keywords

ARALKYLAMINE ACETYLTRANSFERASE; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CITALOPRAM; CLORGYLINE; DESIPRAMINE; FLUOXETINE; MELATONIN; N ACETYLSEROTONIN; NEUROTROPHIN; NEUROTROPHIN 3 RECEPTOR; PROTEIN TYROSINE KINASE A; SELEGILINE; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT EFFECT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DARKNESS; DEPRESSION; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MALE; MOUSE; MUTATION; NIGHT; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE; CIRCADIAN RHYTHM; DEPRESSION; HIPPOCAMPUS; HUMANS; MELATONIN; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPROTECTIVE AGENTS; RECEPTOR, TRKB; RETINA; SEROTONIN;

MUS;

EID: 77649258523     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0912531107     Document Type: Article

References (36)

1. Thoenen H (1991) The changing scene of neurotrophic factors. Trends Neurosci 14:165-170.
2. Encinas M, Iglesias M, Llecha N, Comella JX (1999) Extracellular- regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factormediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J Neurochem 73:1409-1421.
3. Middlemas DS,Meisenhelder J, Hunter T (1994) Identification of TrkB autophosphorylation sites and evidence that phospholipase C-γ 1 is a substrate of the TrkB receptor. J Biol Chem 269:5458-5466.
4. Vaidya VA, Duman RS (2001) Depresssion-Emerging insights from neurobiology. Br Med Bull 57:61-79.
5. Castrén E (2004) Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4:58-64.
6. Groves JO (2007) Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12:1079-1088.
7. Kozisek ME, Middlemas D, Bylund DB (2008) Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther 117:30-51.
8. Ganguly S, Coon SL, Klein DC (2002) Control of melatonin synthesis in the mammalian pineal gland: The critical role of serotonin acetylation. Cell Tissue Res 309:127-137.
9. Klein DC, et al. (1997) The melatonin rhythm-generating enzyme: Molecular regulation of serotonin N-acetyltransferase in the pineal gland. Recent Prog Horm Res 52:307-357 discussion 357-358.
10. Roseboom PH, et al. (1996) Melatonin synthesis: Analysis of the more than 150-fold nocturnal increase in serotonin N-acetyltransferase messenger ribonucleic acid in the rat pineal gland. Endocrinology 137:3033-3045.
11. UzT,ManevH(1998) Circadianexpressionof pineal 5-lipoxygenasemRNA. Neuroreport 9:783-786.
12. Hamada T, et al. (1999) The expression of themelatonin synthesis enzyme: Arylalkylamine N-acetyltransferase in the suprachiasmatic nucleus of rat brain. Biochem Biophys Res Commun 258:772-777.
13. Nosjean O, et al. (2000) Identification of the melatonin-binding site MT3 as the quinone reductase 2. J Biol Chem 275:31311-31317.
14. Brown GM, Pulido O, Grota LJ, Niles LP (1984) N-acetylserotonin in the central nervous system. Prog Neuropsychopharmacol Biol Psychiatry 8:475-480.
15. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56:131-137.
16. Dias BG, Banerjee SB, Duman RS, Vaidya VA (2003) Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45:553-563.
17. Garza AA, Ha TG, Garcia C, Chen MJ, Russo-Neustadt AA (2004) Exercise, antidepressant treatment, and BDNFmRNAexpression in the aging brain. Pharmacol BiochemBehav 77:209-220.
18. Ivy AS, Rodriguez FG, Garcia C, Chen MJ, Russo-Neustadt AA (2003) Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav 75:81-88.
19. Kopp C, Vogel E, Rettori M, Delagrange P, Misslin R (2000) Anxiolytic-like properties of melatonin receptor agonists in mice: Involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness. Neuropharmacology 39:1865-1871.
20. Huang YZ, Pan E, Xiong ZQ, McNamara JO (2008) Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse. Neuron 57:546-558.
21. Chen X, et al. (2005) A chemical-genetic approach to studying neurotrophin signaling. Neuron 46:13-21.
22. Vecino E, et al. (2002) Rat retinal ganglion cells co-express brain derived neurotrophic factor (BDNF) and its receptor TrkB. Vision Res 42:151-157.
23. Rantamäki T, et al. (2007) Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cγ signaling pathways in mouse brain. Neuropsychopharmacology 32:2152-2162.
24. Oxenkrug GF, McCauley R, McIntyre IM, Filipowicz C (1985) Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin. J Neural Transm 61:265-270.
25. Prakhie IV, Oxenkrug GF (1998) The effect of nifedipine, Ca(2+) antagonist, on activity of MAO inhibitors, N-acetylserotonin and melatonin in the mouse tail suspension test. Int J Neuropsychopharmacol 1:35-40.
26. Oxenkrug GF, McIntyre IM, Requintina PJ, Duffy JD (1991) The response of the pineal melatonin biosynthesis to the selective MAO-A inhibitor, clorgyline, in young and middle-aged rats. Prog Neuropsychopharmacol Biol Psychiatry 15:895-902.
27. Dubocovich ML, Mogilnicka E, Areso PM (1990) Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. Eur J Pharmacol 182:313-325.
28. Uz T, Manev H (2001) Prolonged swim-test immobility of serotonin Nacetyltransferase (AANAT)-mutant mice. J Pineal Res 30:166-170.
29. Uz T, Manev H (1999) Chronic fluoxetine administration increases the serotonin Nacetyltransferase messenger RNA content in rat hippocampus. Biol Psychiatry 45:175-179.
30. Trullas R, Jackson B, Skolnick P (1989) Genetic differences in a tail suspension test for evaluating antidepressant activity. Psychopharmacology (Berl) 99:287-288.
31. Li Y, et al. (2008) TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron 59:399-412.
32. Coon SL, Del Olmo E, Young WS III, Klein DC (2002) Melatonin synthesis enzymes in Macaca mulatta: Focus on arylalkylamine N-acetyltransferase (EC 2.3.1.87). J Clin Endocrinol Metab 87:4699-4706.
33. Rajagopal R, Chen ZY, Lee FS, Chao MV (2004) Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J Neurosci 24:6650-6658.
34. Arévalo JC, et al. (2006) Cell survival through Trk neurotrophin receptors is differentially regulated by ubiquitination. Neuron 50:549-559.
35. Doyle SE, Grace MS, McIvor W, Menaker M (2002) Circadian rhythms of dopamine in mouse retina: The role of melatonin. Vis Neurosci 19:593-601.
36. Rios M, et al. (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15:1748-1757.